SNU-626
Resource Report
Resource Website
|
RRID:CVCL_5080
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Korean., Part of: TCGA-110-CL cell line panel., Part of: Seoul National University (SNU) cell line collection., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11776963
PMID:19956504
PMID:22460905
PMID:26589293
PMID:30894373
PMID:31068700
PMID:31395879
|
Cancer cell line
|
Male |
SNU626, NCI-SNU-626 |
|
|
ArrayExpress:E-MTAB-2770,
BioSample:SAMN10988090,
cancercelllines:CVCL_5080,
Cell_Model_Passport:SIDM01444,
DepMap:ACH-000370,
GEO:GSM887637,
GEO:GSM888724,
IARC_TP53:28319,
KCLB:00626,
LiGeA:CCLE_810,
PharmacoDB:SNU626_1475_2019,
Progenetix:CVCL_5080,
Wikidata:Q54955234 |
|
|
CVCL_5080 |
2026-09-12 06:00:57 |
0 |
HBL-100
Resource Report
Resource Website
1+ mentions
Misidentified
Discontinued
Discontinued
|
CLS Cat# 300178, RRID:CVCL_4362
|
Homo sapiens (Human)
|
|
Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124)., Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized..
|
PMID:2547730
PMID:2840847
PMID:2995096
PMID:3109929
PMID:6500159
PMID:6891286
PMID:9671407
PMID:10969801
PMID:11416159
PMID:12661003
PMID:16643607
PMID:17157791
PMID:20143388
PMID:24094812
PMID:24176112
PMID:25485619
PMID:25877200
PMID:26589293
PMID:28889351
|
Transformed cell line
|
Male |
HBL 100, HBL100 |
CLS |
300178 |
BTO:BTO_0004734,
CLO:CLO_0003626,
EFO:EFO_0001167,
CLDB:cl1571,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-TABM-157,
ATCC:HTB-124,
BioSample:SAMN03152011,
BioSample:SAMN03471101,
BioSample:SAMN03472914,
CCRID:1101HUM-PUMC000374,
CCRID:3101HUMGNHu10,
CCTCC:GDC0195,
ChEMBL-Cells:CHEMBL3307713,
ChEMBL-Targets:CHEMBL614811,
CLS:300178,
Cosmic:687471,
Cosmic:877447,
Cosmic:934533,
Cosmic:979722,
Cosmic:991323,
Cosmic:1010933,
Cosmic:1136364,
Cosmic:1176632,
Cosmic:1434949,
Cosmic:1524348,
Cosmic:1609469,
DepMap:ACH-002321,
EGA:EGAS00001000610,
GEO:GSM1053697,
IARC_TP53:21063,
LINCS_HMS:51117,
PharmacoDB:HBL100_443_2019,
PubChem_Cell_line:CVCL_4362,
RCB:RCB0460,
TOKU-E:3589,
Ubigene:YC-C013,
Wikidata:Q54881428 |
|
|
CVCL_4362 |
2026-09-12 06:05:50 |
2 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
CLS Cat# 300194, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
CLS |
300194 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-12 06:05:51 |
39236 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
CLS Cat# 300397, RRID:CVCL_1906
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CLS |
300397 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
cvcl_0030 |
|
CVCL_1906 |
2026-09-12 06:05:51 |
2898 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued
Possibly Discontinued
|
CLS Cat# 300148, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055
PMID:71759
PMID:327080
PMID:833871
PMID:856461
PMID:922665
PMID:2535691
PMID:3518877
PMID:3698005
PMID:5459762
PMID:6401685
PMID:6888561
PMID:6935474
PMID:7037175
PMID:7139592
PMID:7253718
PMID:7459858
PMID:7838528
PMID:8221663
PMID:8490657
PMID:8665486
PMID:9201287
PMID:9283597
PMID:9516836
PMID:11550280
PMID:11668190
PMID:12210830
PMID:12702577
PMID:15390183
PMID:15892104
PMID:16524757
PMID:16822308
PMID:17974978
PMID:20655465
PMID:22213050
PMID:22460905
PMID:24466371
PMID:25485619
PMID:25877200
PMID:25894527
PMID:26589293
PMID:28350380
PMID:30894373
PMID:31068700
PMID:31581737
PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
CLS |
300148 |
BTO:BTO_0000934,
CLO:CLO_0006948,
CLO:CLO_0016777,
EFO:EFO_0001195,
MCCL:MCC:0000242,
CLDB:cl2878,
CLDB:cl2879,
CLDB:cl2880,
CLDB:cl2881,
CLDB:cl2882,
CLDB:cl2883,
CLDB:cl2885,
CLDB:cl2886,
CLDB:cl2887,
CLDB:cl2888,
ABM:T8975,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:CCL-127,
BCRC:60014,
BCRJ:0377,
BioGRID_ORCS_Cell_line:637,
BioSample:SAMN00808348,
BioSample:SAMN03472412,
BioSample:SAMN03473082,
BioSample:SAMN10988103,
cancercelllines:CVCL_0346,
CCRID:1101HUM-PUMC000282,
CCRID:3101HUMTCHu145,
CCRID:4201HUM-CCTCC00107,
CCTCC:GDC0107,
Cell_Model_Passport:SIDM00226,
CGH-DB:78-1,
CGH-DB:9095-4,
ChEMBL-Cells:CHEMBL3307656,
ChEMBL-Targets:CHEMBL614585,
CLS:300148,
Coriell:AG03320,
Coriell:GM03320,
Cosmic:688067,
Cosmic:759892,
Cosmic:801746,
Cosmic:920239,
Cosmic:922658,
Cosmic:947702,
Cosmic:1019944,
Cosmic:1037352,
Cosmic:1099149,
Cosmic:1109111,
Cosmic:1237544,
Cosmic:1518066,
Cosmic:1526626,
Cosmic:2058113,
Cosmic:2131590,
Cosmic:2301580,
Cosmic:2393630,
Cosmic:2485944,
DepMap:ACH-000310,
DSMZ:ACC-165,
DSMZCellDive:ACC-165,
ECACC:86041809,
EGA:EGAS00001000610,
GEO:GSM453632,
GEO:GSM563362,
GEO:GSM692859,
GEO:GSM887162,
GEO:GSM888234,
GEO:GSM1366406,
GEO:GSM1669934,
GEO:GSM2371237,
GEO:GSM2394364,
IARC_TP53:23585,
ICLC:HTL96021,
IZSLER:BS TCL 29,
JCRB:IFO50283,
JCRB:JCRB9050,
KCB:KCB 2011100YJ,
KCLB:10127,
LiGeA:CCLE_016,
LINCS_LDP:LCL-1965,
Lonza:971,
PharmacoDB:IMR32_659_2019,
PRIDE:PXD000589,
Progenetix:CVCL_0346,
PubChem_Cell_line:CVCL_0346,
RCB:RCB1895,
TKG:TKG 0207,
Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-09-12 06:05:54 |
353 |
U-2932
Resource Report
Resource Website
10+ mentions
|
Ubigene Cat# YC-C059, RRID:CVCL_1896
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma activated B-cell type
|
Donor information: Originally the patient was suffering from Hodgkin lymphoma., Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572)., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel.
|
PMID:12533045
PMID:20054396
PMID:23257783
PMID:23292937
PMID:23295736
PMID:25485619
PMID:25894527
PMID:26589293
PMID:27566572
PMID:28196595
PMID:29416618
PMID:29533902
PMID:29666304
PMID:30165192
PMID:31160637
|
Cancer cell line
|
Female |
U2932 |
Ubigene |
YC-C059 |
EFO:EFO_0006499,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-4527,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioSample:SAMN03473452,
cancercelllines:CVCL_1896,
ChEMBL-Cells:CHEMBL4295421,
ChEMBL-Targets:CHEMBL4296507,
Cosmic:1487546,
Cosmic:1517654,
Cosmic:1945196,
DSMZ:ACC-633,
DSMZCellDive:ACC-633,
EGA:EGAS00001000610,
GEO:GSM1035339,
GEO:GSM1059802,
GEO:GSM1374971,
PharmacoDB:U2932_1621_2019,
PRIDE:PXD000589,
Progenetix:CVCL_1896,
PubChem_Cell_line:CVCL_1896,
Ubigene:YC-C059,
Wikidata:Q54973560 |
|
|
CVCL_1896 |
2026-09-12 06:16:57 |
32 |
42-MG-BA
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1798
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9604998
PMID:22460905
PMID:26589293
PMID:27397505
PMID:28464039
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
42MGBA |
|
|
CLO:CLO_0001367,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:440,
BioSample:SAMN03473596,
BioSample:SAMN10988275,
cancercelllines:CVCL_1798,
Cell_Model_Passport:SIDM00982,
Cosmic:687561,
Cosmic:1746946,
Cosmic:1995325,
Cosmic:2060804,
Cosmic:2302328,
Cosmic:2732518,
Cosmic-CLP:687561,
DepMap:ACH-000323,
DSMZ:ACC-431,
DSMZCellDive:ACC-431,
EGA:EGAS00001000978,
GDSC:687561,
GEO:GSM326214,
GEO:GSM886839,
GEO:GSM887902,
GEO:GSM1669567,
IARC_TP53:28274,
LiGeA:CCLE_146,
LINCS_LDP:LCL-1347,
PharmacoDB:42MGBA_16_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1798,
Wikidata:Q54603004 |
|
|
CVCL_1798 |
2026-09-12 06:18:26 |
1 |
537-mel
Resource Report
Resource Website
|
RRID:CVCL_8052
|
Homo sapiens (Human)
|
Melanoma
|
From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
|
PMID:8027550
PMID:8081556
PMID:9670966
PMID:10048982
PMID:10754339
PMID:15467732
PMID:25485619
PMID:25877200
PMID:26589293
PMID:36139163
|
Cancer cell line
|
Male |
537-MEL, 537 mel, 537 MEL, 537mel, 537MEL, 537, Mel537 |
|
|
EFO:EFO_0006357,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03471452,
CGH-DB:9298-4,
Cosmic:876685,
Cosmic:905212,
Cosmic:1507618,
Cosmic:2233664,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
GEO:GSM274694,
PharmacoDB:537MEL_19_2019,
Wikidata:Q54603831 |
|
|
CVCL_8052 |
2026-09-12 06:18:33 |
0 |
59M
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2291
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2653399
PMID:8795574
PMID:15677628
PMID:22460905
PMID:23415752
PMID:23839242
PMID:25230021
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27561551
PMID:28196595
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
OAW59M, OAW 59M, 59 M |
|
|
CLO:CLO_0001428,
EFO:EFO_0006358,
CLDB:cl110,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:498,
BioSample:SAMN03472466,
BioSample:SAMN10988041,
cancercelllines:CVCL_2291,
Cell_Model_Passport:SIDM01528,
DepMap:ACH-000520,
ECACC:89081802,
EGA:EGAS00001000610,
GEO:GSM313717,
GEO:GSM887904,
GEO:GSM1291125,
GEO:GSM1374376,
IARC_TP53:28342,
LiGeA:CCLE_458,
PharmacoDB:59M_21_2019,
PRIDE:PXD003668,
Progenetix:CVCL_2291,
Wikidata:Q54604004 |
|
|
CVCL_2291 |
2026-09-12 06:18:34 |
3 |
639V
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1048
|
Homo sapiens (Human)
|
Ureter urothelial carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:66978
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:8873383
PMID:20164919
PMID:20215515
PMID:22460905
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27397505
PMID:29732388
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
639v, 639-V, 639 V |
|
|
CLO:CLO_0001448,
EFO:EFO_0002097,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-109,
BioGRID_ORCS_Cell_line:499,
BioSample:SAMN03473587,
BioSample:SAMN10989559,
cancercelllines:CVCL_1048,
Cell_Model_Passport:SIDM00999,
ChEMBL-Cells:CHEMBL3308703,
ChEMBL-Targets:CHEMBL1075383,
Cosmic:906798,
Cosmic:923375,
Cosmic:928821,
Cosmic:1285104,
Cosmic:1927315,
Cosmic:2050428,
Cosmic:2685931,
Cosmic-CLP:906798,
DepMap:ACH-000973,
DSMZ:ACC-413,
DSMZCellDive:ACC-413,
EGA:EGAS00001000978,
GDSC:906798,
GEO:GSM827155,
GEO:GSM886841,
GEO:GSM887905,
GEO:GSM1567846,
GEO:GSM1574552,
GEO:GSM1574584,
GEO:GSM1669569,
IARC_TP53:6601,
IGRhCellID:639V,
LiGeA:CCLE_355,
LINCS_LDP:LCL-1943,
PharmacoDB:639V_24_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1048,
PubChem_Cell_line:CVCL_1048,
Wikidata:Q52155313 |
|
|
CVCL_1048 |
2026-09-12 06:18:37 |
3 |
624-mel
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_8054
|
Homo sapiens (Human)
|
Melanoma
|
From: Rosenberg, Steven A.; Surgery Branch, National Cancer Institute, National Institutes of Health; Bethesda; USA.
|
PMID:8027550
PMID:8081556
PMID:8537970
PMID:9759882
PMID:10048982
PMID:10754339
PMID:15467732
PMID:15592718
PMID:19340423
PMID:23851445
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27600516
|
Cancer cell line
|
Male |
624-MEL, 624 MEL, 624 Mel, 624 mel, 624mel, 624MEL, 624, Mel-624, Mel624, MEL624 |
|
|
BTO:BTO_0002951,
EFO:EFO_0006359,
ArrayExpress:E-MTAB-2706,
BioGRID_ORCS_Cell_line:754,
BioSample:SAMN03471309,
cancercelllines:CVCL_8054,
CGH-DB:9301-4,
ChEMBL-Cells:CHEMBL3885941,
Cosmic:876683,
Cosmic:905214,
Cosmic:1303044,
Cosmic:1559441,
Cosmic:2163793,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
ESTDAB:ESTDAB-049,
GEO:GSM206438,
GEO:GSM274692,
PharmacoDB:624mel_23_2019,
PubChem_Cell_line:CVCL_8054,
Wikidata:Q54604356 |
|
|
CVCL_8054 |
2026-09-12 06:18:37 |
21 |
23132/87
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-201, RRID:CVCL_1046
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8100658
PMID:11668190
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24807215
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
23132-87, 2313287, St 23132, St23132, 23132 |
DSMZ |
ACC-201 |
CLO:CLO_0001202,
EFO:EFO_0006528,
CLDB:cl38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:822,
BioSample:SAMN03470944,
BioSample:SAMN03473375,
BioSample:SAMN10988573,
cancercelllines:CVCL_1046,
Cell_Model_Passport:SIDM00980,
ChEMBL-Cells:CHEMBL3308702,
ChEMBL-Targets:CHEMBL1075382,
Cosmic:910924,
Cosmic:1995324,
Cosmic:2484956,
Cosmic-CLP:910924,
DepMap:ACH-000948,
DSMZ:ACC-201,
DSMZCellDive:ACC-201,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910924,
GEO:GSM827572,
GEO:GSM886838,
GEO:GSM887901,
GEO:GSM1374371,
GEO:GSM1374372,
GEO:GSM1669566,
IARC_TP53:21150,
LiGeA:CCLE_415,
LINCS_LDP:LCL-1532,
PharmacoDB:2313287_13_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1046,
PubChem_Cell_line:CVCL_1046,
Wikidata:Q54583395 |
|
|
CVCL_1046 |
2026-09-12 06:18:01 |
2 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978
PMID:327080
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:3708594
PMID:4431054
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7658585
PMID:8873383
PMID:11207054
PMID:11416159
PMID:11921286
PMID:12127398
PMID:15846775
PMID:16885334
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27270441
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
|
|
BTO:BTO_0004796,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-108,
BioSample:SAMN10987961,
cancercelllines:CVCL_7935,
Cell_Model_Passport:SIDM01529,
Cosmic:715794,
Cosmic:760476,
Cosmic:845564,
Cosmic:925827,
Cosmic:928820,
Cosmic:1016884,
Cosmic:1046680,
Cosmic:1082644,
Cosmic:1285102,
Cosmic:1285997,
Cosmic:1927305,
Cosmic:1938694,
Cosmic:2050426,
Cosmic:2057433,
Cosmic:2444255,
Cosmic:2685929,
Cosmic:2700994,
DepMap:ACH-000011,
GEO:GSM136240,
GEO:GSM1574546,
GEO:GSM1574574,
IARC_TP53:21034,
KCLB:80001,
LiGeA:CCLE_259,
PharmacoDB:253J_14_2019,
Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-09-12 06:18:04 |
5 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
KCLB Cat# 80001, RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978
PMID:327080
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:3708594
PMID:4431054
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7658585
PMID:8873383
PMID:11207054
PMID:11416159
PMID:11921286
PMID:12127398
PMID:15846775
PMID:16885334
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27270441
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
KCLB |
80001 |
BTO:BTO_0004796,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-108,
BioSample:SAMN10987961,
cancercelllines:CVCL_7935,
Cell_Model_Passport:SIDM01529,
Cosmic:715794,
Cosmic:760476,
Cosmic:845564,
Cosmic:925827,
Cosmic:928820,
Cosmic:1016884,
Cosmic:1046680,
Cosmic:1082644,
Cosmic:1285102,
Cosmic:1285997,
Cosmic:1927305,
Cosmic:1938694,
Cosmic:2050426,
Cosmic:2057433,
Cosmic:2444255,
Cosmic:2685929,
Cosmic:2700994,
DepMap:ACH-000011,
GEO:GSM136240,
GEO:GSM1574546,
GEO:GSM1574574,
IARC_TP53:21034,
KCLB:80001,
LiGeA:CCLE_259,
PharmacoDB:253J_14_2019,
Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-09-12 06:18:04 |
5 |
Caki-2
Resource Report
Resource Website
100+ mentions
Misclassified
|
CancerTools Cat# 161904, RRID:CVCL_0235
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a clear cell renal cell carcinoma but shown to be from a papillary renal cell carcinoma (PubMed=17409424; PubMed=27993170)..
|
PMID:327080
PMID:571047
PMID:833871
PMID:3518877
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7591954
PMID:10723130
PMID:10929426
PMID:15585611
PMID:17409424
PMID:20215515
PMID:22185343
PMID:22460905
PMID:22949125
PMID:25485619
PMID:25877200
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
CAKI-2, CaKi-2, caki-2, CAKI 2, Caki 2, Caki2, CAKI2 |
CancerTools |
161904 |
BTO:BTO_0006204,
CLO:CLO_0002177,
EFO:EFO_0002150,
MCCL:MCC:0000124,
CLDB:cl625,
CLDB:cl626,
CLDB:cl627,
CLDB:cl629,
4DN:4DNSRDD5W2FZ,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-47,
BCRJ:0408,
BioGRID_ORCS_Cell_line:583,
BioSample:SAMN01821542,
BioSample:SAMN01821619,
BioSample:SAMN03471873,
BioSample:SAMN10988361,
cancercelllines:CVCL_0235,
CancerTools:161904,
CCRID:1101HUM-PUMC000337,
Cell_Model_Passport:SIDM01546,
ChEMBL-Cells:CHEMBL3308071,
ChEMBL-Targets:CHEMBL613852,
CLS:300140,
Cosmic:687941,
Cosmic:874612,
Cosmic:877458,
Cosmic:979706,
Cosmic:982278,
Cosmic:1152536,
Cosmic:2520633,
DepMap:ACH-000234,
DSMZ:ACC-54,
DSMZCellDive:ACC-54,
ECACC:93120819,
EGA:EGAS00001000610,
ENCODE:ENCBS074UKQ,
ENCODE:ENCBS461KDA,
ENCODE:ENCBS611WID,
ENCODE:ENCBS768KGZ,
ENCODE:ENCBS787YGO,
GEO:GSM374478,
GEO:GSM886903,
GEO:GSM887968,
IARC_TP53:30022,
ICLC:HTL95029,
IGRhCellID:Caki2,
IZSLER:BS TCL 8,
KCLB:30047,
LiGeA:CCLE_157,
PharmacoDB:Caki2_164_2019,
PRIDE:PXD000335,
PRIDE:PXD003105,
Progenetix:CVCL_0235,
PubChem_Cell_line:CVCL_0235,
Wikidata:Q54808377 |
|
|
CVCL_0235 |
2026-09-12 06:15:14 |
278 |
ALL-SIL
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1805
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127147
PMID:8641406
PMID:10071127
PMID:10739008
PMID:11226526
PMID:14504097
PMID:15361874
PMID:15472075
PMID:17117183
PMID:22675565
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35354797
PMID:35839778
|
Cancer cell line
|
Male |
ALLSIL, SIL-ALL, Sil-ALL |
|
|
BTO:BTO_0005360,
CLO:CLO_0037168,
EFO:EFO_0022414,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473514,
BioSample:SAMN10988449,
cancercelllines:CVCL_1805,
Cell_Model_Passport:SIDM00994,
Cosmic:721715,
Cosmic:913404,
Cosmic:933537,
Cosmic:996306,
Cosmic:998724,
Cosmic:1037687,
Cosmic:1115585,
Cosmic:1175126,
Cosmic:1224372,
Cosmic:1330498,
Cosmic:1524789,
Cosmic:1641391,
Cosmic:1664519,
Cosmic:1760517,
Cosmic:2165718,
Cosmic:2602907,
Cosmic-CLP:1295740,
DepMap:ACH-000105,
DSMZ:ACC-511,
DSMZCellDive:ACC-511,
EGA:EGAS00001000978,
GDSC:1295740,
GEO:GSM1669597,
GEO:GSM5137707,
LiGeA:CCLE_156,
LINCS_LDP:LCL-2059,
PharmacoDB:ALLSIL_59_2019,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_1805,
Wikidata:Q54749231 |
|
|
CVCL_1805 |
2026-09-12 06:21:23 |
6 |
AM-38
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1070
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7947440
PMID:8145054
PMID:12068308
PMID:16232199
PMID:20164919
PMID:22460905
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
AM38, AM |
|
|
CLO:CLO_0009880,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:829,
BioSample:SAMN03470932,
BioSample:SAMN10987853,
cancercelllines:CVCL_1070,
Cell_Model_Passport:SIDM00492,
CGH-DB:139-1,
ChEMBL-Cells:CHEMBL3308829,
ChEMBL-Targets:CHEMBL2366192,
Cosmic:685873,
Cosmic:910933,
Cosmic:1746962,
Cosmic:2302334,
Cosmic:2367507,
Cosmic:2516013,
Cosmic-CLP:910933,
DepMap:ACH-000269,
EGA:EGAS00001000978,
GDSC:910933,
GEO:GSM326247,
GEO:GSM886866,
GEO:GSM887931,
GEO:GSM1669598,
IARC_TP53:21174,
JCRB:IFO50492,
LiGeA:CCLE_669,
LINCS_LDP:LCL-1366,
PharmacoDB:AM38_60_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1070,
PubChem_Cell_line:CVCL_1070,
Wikidata:Q54749551 |
|
|
CVCL_1070 |
2026-09-12 06:21:26 |
7 |
AML-193
Resource Report
Resource Website
1+ mentions
Discontinued
Possibly Discontinued
|
RRID:CVCL_1071
|
Homo sapiens (Human)
|
Childhood acute myeloid leukemia
|
Characteristics: CSF2, IL3 and IL6 dependent., Population: African American and Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2015403
PMID:2656885
PMID:3496132
PMID:9195772
PMID:12068308
PMID:16408098
PMID:20164919
PMID:21989985
PMID:22460905
PMID:25984343
PMID:26589293
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
AML193 |
|
|
BTO:BTO_0006203,
CLO:CLO_0001718,
EFO:EFO_0022399,
CLDB:cl272,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-9589,
ATCC:HTB-188,
BCRJ:0040,
BioSample:SAMN01821616,
BioSample:SAMN03471219,
BioSample:SAMN10987604,
cancercelllines:CVCL_1071,
CCRID:3101HUMTCHu207,
Cell_Model_Passport:SIDM01525,
Cosmic:724816,
Cosmic:787420,
Cosmic:949089,
Cosmic:975238,
Cosmic:1012057,
Cosmic:1281305,
Cosmic:2306199,
Cosmic:2750853,
DepMap:ACH-000557,
DSMZ:ACC-549,
DSMZCellDive:ACC-549,
GEO:GSM886867,
GEO:GSM887932,
IARC_TP53:27144,
LiGeA:CCLE_497,
Lonza:1685,
PharmacoDB:AML193_61_2019,
Progenetix:CVCL_1071,
Wikidata:Q54749799 |
|
|
CVCL_1071 |
2026-09-12 06:21:27 |
1 |
AN3-CA
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0028
|
Homo sapiens (Human)
|
Acanthosis nigricans
|
Population: Caucasian., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080
PMID:3518877
PMID:6220172
PMID:11668190
PMID:14207855
PMID:16957166
PMID:20164919
PMID:20215515
PMID:20218740
PMID:20944090
PMID:22460905
PMID:22710073
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
AN3_CA, AN3 CA, AN3 Ca, AN3CA, AN-3, AN3, Acanthosis Nigricans 3rd attempt-CArcinoma |
|
|
BTO:BTO_0001771,
CLO:CLO_0001722,
CLO:CLO_0037160,
EFO:EFO_0002110,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-111,
BCRJ:0363,
BioSample:SAMN03471092,
BioSample:SAMN03473131,
BioSample:SAMN03473336,
BioSample:SAMN10988375,
cancercelllines:CVCL_0028,
CCRID:4201HUM-CCTCC00127,
CCTCC:GDC0127,
Cell_Model_Passport:SIDM00901,
ChEMBL-Cells:CHEMBL3308708,
ChEMBL-Targets:CHEMBL1075392,
CLS:300119,
Cosmic:687550,
Cosmic:699283,
Cosmic:713473,
Cosmic:713495,
Cosmic:809134,
Cosmic:846176,
Cosmic:871551,
Cosmic:889116,
Cosmic:910781,
Cosmic:980634,
Cosmic:1007162,
Cosmic:1057760,
Cosmic:1066221,
Cosmic:1070810,
Cosmic:1102376,
Cosmic:1105620,
Cosmic:1177683,
Cosmic:1223484,
Cosmic:1434192,
Cosmic:1576450,
Cosmic:1622894,
Cosmic:1696752,
Cosmic:2030460,
Cosmic:2646618,
Cosmic-CLP:910781,
DepMap:ACH-000940,
DSMZ:ACC-267,
DSMZCellDive:ACC-267,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910781,
GEO:GSM374970,
GEO:GSM375429,
GEO:GSM827494,
GEO:GSM886869,
GEO:GSM887934,
GEO:GSM1669600,
GEO:GSM3161710,
GEO:GSM3161711,
GEO:GSM7701431,
GEO:GSM7701432,
IARC_TP53:21175,
IGRhCellID:AN3CA,
IZSLER:BS TCL 200,
LiGeA:CCLE_574,
LINCS_LDP:LCL-1499,
PharmacoDB:AN3CA_63_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0028,
PubChem_Cell_line:CVCL_0028,
TOKU-E:543,
Wikidata:Q54749896 |
|
|
CVCL_0028 |
2026-09-12 06:21:28 |
17 |
L-540
Resource Report
Resource Website
1+ mentions
|
CLS Cat# 300201, RRID:CVCL_1362
|
Homo sapiens (Human)
|
Hodgkin lymphoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2690233
PMID:6303739
PMID:6305805
PMID:7276066
PMID:7530238
PMID:8558920
PMID:11021758
PMID:12581897
PMID:17065008
PMID:20164919
PMID:20628145
PMID:22460905
PMID:25355872
PMID:25894527
PMID:26589293
PMID:27397505
PMID:29533902
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
L 540, L540 |
CLS |
300201 |
BTO:BTO_0005176,
CLO:CLO_0007201,
EFO:EFO_0022416,
CLDB:cl455,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473399,
BioSample:SAMN10988507,
cancercelllines:CVCL_1362,
Cell_Model_Passport:SIDM00329,
ChEMBL-Cells:CHEMBL3308531,
ChEMBL-Targets:CHEMBL2366153,
CLS:300201,
Cosmic:907323,
Cosmic:988705,
Cosmic:1013911,
Cosmic:1086359,
Cosmic:1432039,
Cosmic:2276327,
Cosmic:2464307,
Cosmic-CLP:907323,
DepMap:ACH-000806,
DSMZ:ACC-72,
DSMZCellDive:ACC-72,
EGA:EGAS00001000978,
GDSC:907323,
GEO:GSM335392,
GEO:GSM499725,
GEO:GSM499726,
GEO:GSM552448,
GEO:GSM646532,
GEO:GSM646535,
GEO:GSM887261,
GEO:GSM888336,
GEO:GSM1670030,
IARC_TP53:21456,
IARC_TP53:23615,
LiGeA:CCLE_220,
LINCS_LDP:LCL-2012,
PharmacoDB:L540_816_2019,
PRIDE:PXD000589,
PRIDE:PXD030304,
Progenetix:CVCL_1362,
PubChem_Cell_line:CVCL_1362,
Wikidata:Q54900876 |
|
|
CVCL_1362 |
2026-09-12 06:16:11 |
4 |
